MEMert Evlice

Mert Evlice

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mert Evlice has a total of 107 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hemodynamic Reclassification Under the 2022 Definition in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Single-Center Cohort Study

    by Burak Okyar, Mert Evlıce, Emre Paçacı, Bekir Akmaz, İlHan Kaplan, Halil Coşkun, Mükremin Coşkun, Alper Yıldırım, Emine Duygu Ersözlü, İbRahim Halil Kurt

    Introduction/Objectives: The 2022 pulmonary hypertension guidelines lowered the hemodynamic thresholds for pulmonary hypertension and pulmonary arterial hypertension, potentially expanding the spectrum of connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH). The profile of patients identified only by the updated definition remains incompletely characterized. To evaluate the reclassification impact of the 2022 hemodynamic definition in a catheterization-based cohort of clinically adjudicated CTD-associated Group 1 PAH.Methods: We retrospectively analyzed 27 patients with CTD-associated Group 1 PAH. Patients fulfilling previous mPAP and PVR thresholds were classified as established PAH, whereas those fulfilling the 2022 classification but not the previous definition were classified as 2022-only early CTD-PAH. Clinical, pulmonary function, echocardiographic, and hemodynamic variables were compared. Exploratory high burden was defined as ≥4 positive components among PVR ≥5 WU, mPAP ≥35 mmHg, right atrial mean pressure ≥8 mmHg, cardiac index

  • Open Access

    Fluoroquinolone Exposure and Coronary Artery Ectasia: A Retrospective Angiography-Based Case-Control Study

    by Ömer Bedir, Mükremin Coşkun, Murat Gençaslan, Remziye Doğan, Ömer Kümet, Mert Evlıce

    Objective: Fluoroquinolones have been linked to collagen-related adverse events and aortic aneurysm or dissection, but their relationship with coronary artery ectasia (CAE) is unknown. We evaluated whether documented systemic fluoroquinolone exposure was associated with angiographically defined CAE and with CAE anatomic phenotype. Material and Methods: In this retrospective case-control study, 530 adults undergoing coronary angiography between January 2023 and May 2024 were included: 267 with CAE and 263 angiographic controls. The exposure was documented systemic fluoroquinolone use before angiography, ascertained from institutional prescribing and medication records. Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) with sequential adjustment for demographics, cardiovascular risk factors, angiographic indication, and other antibiotic and non-steroidal anti-inflammatory drug exposure. Cumulative dose, active-comparator, overlap-weighted, and case-only analyses were supportive. Results: Fluoroquinolone exposure was present in 152 of 267 cases (56.9%) and 71 of 263 controls (27.0%). The unadjusted OR was 3.57, 95% CI [2.48, 5.15]; the association persisted after adjustment for measured clinical and medication covariates, OR = 3.83, 95% CI [2.61, 5.62], p < .001. Among 223 exposed participants, an exploratory dose trend was detected (adjusted OR per category = 2.55, 95% CI [1.66, 3.91], p < .001). Findings were consistent in active-comparator and overlap-weighted analyses. Among cases, no statistically significant association with multivessel or diffuse Markis type I/II CAE was detected. Conclusion: Documented fluoroquinolone exposure was associated with CAE after adjustment for measured covariates; no statistically significant association with angiographic extent was detected among CAE cases. These findings are hypothesis-generating and require confirmation in multicenter, pharmacy-linked studies.

  • Open Access

    Amoxicillin-clavulanic Acid-induced Kounis Syndrome

    by Mert Evli̇cE, İlHan Kaplan, Halil Coşkun, Burak Cabbar Karakurt, Mükremin Coşkun

    Amoxicillin-clavulanic Acid-induced Kounis Syndrome - Journal of Eurasian Medical Science

  • Assessment of Aortic Arch Wall Motion Velocities in Severe Aortic Stenosis: A Transthoracic and Transesophageal Echocardiography Study

    by Abdullah Yildirim, Omer Genc, Emre Sezici, Fadime Koca, Guluzar Tras, Ahmet Suha Arslan, Emre Pacaci, Mustafa Lutfullah Ardic, Gokhan Alici, Mukremin Coskun, et al.

    Background: This study aimed to evaluate the diagnostic utility of a novel parameter—arcus aorta wall motion velocities (AA‐WMV)—measured by pulse‐wave tissue Doppler imaging (PW‐TDI) during TEE, and to compare its performance with established stiffness indices. Methods: In this prospective study, 196 patients with aortic stenosis (AS) and 128 controls without AS underwent TEE. AA‐WMV parameters—systolic (Vs) and diastolic (Vd) velocities—were assessed using PW‐TDI of the aortic arch. Conventional aortic stiffness markers, including valvuloarterial impedance (ZVA), total arterial compliance index (TAC ‐index ), pulse wave velocity, and aortic intima‐media thickness (Ao‐IMT), were also measured. Results: Vs (3.35 ± 0.73 vs. 4.08 ± 0.69 cm/s, p <  0.001) and Vd (2.65 ± 0.98 vs. 3.67 ± 0.65 cm/s, p < 0.001) were significantly lower in AS patients compared to controls. In multivariable logistic regression, Vs (aOR:0.27, 95% CI: 0.14–0.55, p <  0.001) and Vd (aOR:0.14, 95% CI: 0.07–0.31, p <  0.001) remained independent predictors of AS, alongside stroke volume‐index and interventricular septal thickness. ROC analysis demonstrated the highest discriminative capacity for Vd (AUC =  0.837), followed by Vs (AUC =  0.783). The combined Vs+Vd model yielded optimal performance (C ‐index =  0.87), improved calibration (Brier score =  0.145), and superior model fit (pseudo‐R 2 =  0.337, AIC =  274.3). Compared to the Vs model alone, the combined model significantly improved reclassification metrics, including net reclassification improvement (NRI =  105.6%, p <  0.001), integrated discrimination improvement (IDI =  18.7%, p <  0.001), and median improvement index (4.9%, p <  0.001). The Vs+Vd model also provided greater net clinical benefit. Conclusions: AA‐WMV parameters—particularly Vd—offer a simple, reproducible, and effective approach for evaluating aortic stiffness in AS. While Vs and Vd individually hold diagnostic value, their combined use enhances discriminatory and prognostic accuracy, surpassing traditional aortic stiffness indices in patients undergoing TEE.


  • Open Access

    Peripheral venous pressure measurements to evaluate congestion in pulmonary arterial hypertension

    by Mükremin Coşkun, Abdullah Yildirim, Abdullah Eren Çetin, Emre Paçaci, Emre Sezici, Halil Coşkun, Mustafa Ozan Gürsoy, İbRahim Halil Kurt, Mert Evlice

    Background: Right atrial pressure (RAP) is an important prognostic criterion in pulmonary hypertension. Elevated mean RAP measured by cardiac catheterization is an independent risk factor for mortality. Accurate bedside assessment of congestion in the management of patients with PH remains challenging. As a continuous conduit of circulating fluid, systemic congestion represented by high RAP may be reflected by peripheral venous pressure (PVP). We evaluated the reliability of PVP measurements for assessing congestion beyond conventional clinical assessments. Methods: We performed conventional congestion assessments and PVP measurements in 138 patients undergoing right heart catheterization. PVP was measured via the 16-gauge peripheral venous access placed in the upper extremity. Results: The mean RAP and PVP were 8.7 ± 4.2 mm Hg and 10.7 ± 4.3 mm Hg, respectively. PVP exhibited a strong linear correlation with RAP (Pearson R = 0.839; P < .001). PVP demonstrated significant discriminatory power for both RAP < 8 mm Hg (area under the curve: 0.91 [95% confidence interval: 0.86 to 0.96]; sensitivity: 72%; specificity: 94% cutoff: 8.5 mm Hg) and RAP ≥ 12 mm Hg (area under the curve: 0.92 [0.87 to 0.97]; sensitivity: 82%; specificity: 89% cutoff: 12.5 mm Hg). Conclusion: PVP measured via peripheral venous access strongly correlates with invasively obtained RAP. PVP measurements may improve current bedside assessments of congestion.

  • Predictive power of ALBI score-based nomogram for 30-day mortality following transcatheter aortic valve implantation

    by Abdullah Yildirim, Omer Genc, Mert Evlice, Aslan Erdogan, Emre Pacaci, Ahmet Ozderya, Murat Gokhan Yerlikaya, Emre Sezici, Yeliz Guler, Omer Sen, et al.

    This retrospective, multi-center study evaluates the relationships between novel liver function scoring systems - Albumin-Bilirubin (ALBI) score, EZ-ALBI, PALBI, and MELD-XI - and outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Feature importance was assessed with SHAP-values via the XGBoost-algorithm. The ALBI score exhibited the strongest association with 30-day mortality after TAVI (AUC = 0.723, p < 0.001), outperforming other scores in this regard and consistently demonstrating predictive power across various subgroup populations. Higher 30-day mortality rates were observed in the higher tertiles of the ALBI score compared to the lower tertiles (log-rank p-value = 0.004). The ALBI-based nomogram (C-index = 0.81, 95% CI:0.73-0.86, p = 0 < 001) demonstrated superior predictive power for 30-day mortality post-TAVI compared to the STS (C-index = 0.71, 95% CI :0.64-0.77, p = 0 < 001). In addition, the nomogram showed a significant improvement in reclassification (69.3%, p < 0.001) and a stronger discrimination 15.2%, p < 0.001) compared to the STS. It integrates nine variables, first ALBI score (SHAP:1.165), including NYHA class (0.594), body mass index (0.510), glomerular filtration rate, creatinine, hemoglobin, gender, predilatation requirement, presence of chronic kidney disease, and providing a comprehensive risk assessment tool. This study exhibits the significance of liver dysfunction with AS patients and suggests incorporating liver function parameters in pre-operative risk assessments for better clinical outcomes in TAVI procedures.


  • Open Access

    Evaluation of diastolic wall strain in patients with mitral valve regurgitation

    by Mükremin Coşkun, Mert Evlıce, İbRahim Halil Kurt, Mehmet Akif Düzenli

    Background: Diastolic wall strain (DWS) is a non invasive, easy, echocardiographic parameter that has been used to determine left ventricular diastolic stiffness. The relationship between left ventricle functions and diastolic wall strain is previously revealed but we don’t know if this method correlates with mitral regurgitation (MR) severity or not. In this study, we sought to determine the relationship between DWS and MR. Methods: This study included 107 subjects with primary mitral regurgitation, divided in two groups as mild-to-moderate and severe mitral regurgitation, and 54 control subjects. We calculated the DWS from the M-mode echocardiographic measurements of the LV posterior wall thickness at end-systole and end-diastole during sinus rhythm. Results: MR group had lower values of DWS than control subjects and severe MR group had the lowest ones (0.38 ± 0.06; 0.27 ± 0.07; 0.15 ± 0.035 respectively and p

  • Open Access

    The Impact of Transcatheter or Surgical Defect Closure on Self- Reported Sleep Quality in Adults with Atrial Septal Defect

    by Mert Evlice, Sinem Berik Safçı, Emre Paçacı, Samet Ayna, Sinan Cerşit, Lütfi Öcal, Mustafa Ozan Gürsoy, Abdullah Yıldırım, İbrahim Halil Kurt

    Objective: Sleep quality in those with cardiovascular disease is significantly lower than in the general population. This study aimed to explore the effect of transcatheter or surgical closure of atrial septal defect (ASD) on sleep quality. Methods: One hundred nineteen adult patients with ASD who underwent transcatheter or surgical closure were included in the study. Sleep quality was investigated prospectively just before defect closure and six months after defect closure. Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality of these patients. Results: PSQI scores were similar in both groups before the procedure in patients who underwent both transcatheter and surgical closure. The PSQI scores six months after transcatheter closure was significantly improved compared to the PSQI score before transcatheter ASD closure (3.5 +/- 2.0 vs. 6.9 +/- 3.4, respectively; P<0.001). The PSQI scores six months after surgical ASD closure was significantly improved compared to the PSQI score before surgical closure (4.8 +/- 2.1 vs. 7.1 +/- 2.0, respectively; P<0.001). Total PSQI scores were also statistically different at six months after transcatheter and surgical closure (3.5 +/- 2.0 vs. 4.8 +/- 2.1, P=0.014). However, six months after both transcatheter and surgical closure, PSQI scores were significantly decreased in both groups which was more pronounced in patients who underwent transcatheter closure. Conclusion: Transcatheter or surgical closure of the defect may be beneficial in improving the sleep quality of adult patients with ASD. Delayed improvement of sleep quality after surgical closure may be an important advantage for transcatheter closure.

  • The relationship between echocardiographic parameters and albumin bilirubin score in patients with acute pulmonary thromboembolism

    by Mert Evlice, İbRahim H Kurt

    Purpose: The Albumin-Bilirubin (ALBI) score is useful and easy-to-use for objectively assessing liver function. We investigated whether the ALBI score, a parameter indicating liver stiffness, congestion and fibrosis, has any relationship with echocardiographic parameters in patients with acute pulmonary thromboembolism (PTE). Material and Methods: A total of 140 patients diagnosed with acute PTE were retrospectively analyzed. These patients were divided into three groups according to the hemodynamic severity of acute PTE: Group I [Low risk]; Group II [Submassive or intermediate-risk]; and Group III [Massive or high-risk]. Biochemical data obtained from venous blood samples taken at admission were analyzed. In addition, data were also analyzed from transthoracic echocardiography and pulmonary computed tomographic angiography performed at admission. ALBI, Bova, and PESI scores were calculated. Results: ALBI scores (−3.32 ± 0.21 vs −2.86 ± 0.15 vs −2.46 ± 0.2, p < .001) were statistically significantly higher in Group III than Groups I and II. There was a significant difference between the three groups in terms of echocardiographic parameters, and LVEF and TAPSE values tended to decrease from group I to group III. In multivariate linear regression analysis, sPAP, RV/RA diameter, and NT-pro-BNP were found to be significantly associated with the ALBI score. An ALBI score higher than −2.87 was associated with Bova stage II-III in patients with Group I and Group II PTE, with a sensitivity of 87% and a specificity of 62% (AUC = 0.804; 95% CI 0.713–0.895; p < .001). Conclusion: The ALBI score, which is a common, easy-to-use, and inexpensive method, may be beneficial to select intermediate and high-risk patients in patients with acute PTE. Additionally, it may have prognostic value in distinguishing low and intermediate-risk acute PTE patients.